Doc re. Placing Programme

RNS Number : 7074E
Polar Capital Global Financials Tst
14 March 2022
 

14 March 2022

 

Polar Capital Global Financials Trust plc

LEI: 549300G5SWN8EP2P4U41

 

 

Placing Programme

 

Polar Capital Global Financials Trust plc ("the Company") published its Annual Report and Financial Statements for the year ended 31 November 2021 on 10 March 2022 and the current placing programme established by the prospectus published by the Company on 12 May 2021 is due to terminate on 11 May 2022. 

 

Only two months of the placing programme remain unexpired during which the Company will in any event be able to issue up to 21,897,893 ordinary shares under the shareholder authorities obtained at the General Meeting held on 1 February 2022 (together with any further ordinary shares authorised by renewal of such authorities at the Company's Annual General Meeting to be held on Thursday, 7 April 2022). The Directors have accordingly decided not to publish a supplementary prospectus that would otherwise be required to incorporate financial information extracted from the Annual Report and Financial Statements . As a result, the placing programme will terminate with immediate effect. The Company will in due course give consideration to the issue of a further prospectus and the creation of a new placing programme, subject to prevailing market conditions; any such further prospectus would include such financial information. 

 

 

 

Contact details for queries:

 

Polar Capital Global Financials Trust plc

 

Chairman:

Robert Kyprianou

 

Company Secretary:

Tracey Lago, FCG

 

Tel: 020 7227 2700

 

Polar Capital LLP

Investment Manager

 

Sales:

John "Reg" Regnier-Wilson

 

Co-Investment Manager:

Nick Brind

 

Tel: 020 7227 2700

 

Stifel Nicolaus Europe Limited

 

Corporate:

Mark Bloomfield

Jonathan Wilkes-Green

Jack McAlpine

 

Sales:

Phil Hopkins

Jonathan Crabtree

Hugh Middleton

 

Tel: 020 7710 7600 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCXZLFFLXLEBBE
Investor Meets Company
UK 100